Gene Editing for Common Diseases Prompts Call for Stricter Ethical Guidelines

Cardiologists from the University of Michigan Health Frankel Cardiovascular Center are advocating for new criteria to justify genomic therapies as gene editing advances to treat common conditions like high cholesterol, heart disease, obesity, and diabetes. This initiative aims to address ethical and practical considerations, sparking important discussions on the responsible development and application of these emerging treatments.